McMillan MT, Pan X, Smith AL, Newman DK, Weiss SR, Ruggieri MR, S, Malykhina AP. Coronavirus-induced demyelination of neural pathways triggers neurogenic bladder overactivity in a mouse model of multiple sclerosis. Am J Physiol Renal Physiol 307: F612-F622, 2014. First published July 9, 2014 doi:10.1152/ajprenal.00151.2014In the present study, we aimed to determine whether mice with coronavirus-induced encephalomyelitis (CIE) develop neurogenic bladder dysfunction that is comparable with the neurogenic detrusor overactivity observed in patients with multiple sclerosis. Adult mice (C57BL/6J, 8 wk of age, n ϭ 146) were inoculated with a neurotropic strain of mouse hepatitis virus (A59 strain) and followed for 4 wk. Inoculation with the virus caused a significant neural deficit in mice with an average clinical symptom score of 2.6 Ϯ 0.5 at 2 wk. These changes were accompanied by 25 Ϯ 5% weight loss at 1 and 2 wk postinoculation (P Յ 0.001 vs. baseline) followed by a recovery phase. Histological analysis of spinal cord sections revealed multifocal sites of demyelinated lesions. Assessment of micturition patterns by filter paper assay determined an increase in the number of small and large urine spots in CIE mice starting from the second week after inoculation. Cystometric recordings in unrestrained awake animals confirmed neurogenic bladder overactivity at 4 wk postinoculation. One week after inoculation with the A59 strain of mouse hepatitis virus, mice became increasingly sensitive to von Frey filament testing with responses enhanced by 45% (n ϭ 8, P Յ 0.05 vs. baseline at 4 g); however, this initial increase in sensitivity was followed by gradual and significant diminution of abdominal sensitivity to mechanical stimulation by 4 wk postinoculation. Our results provide direct evidence showing that coronavirus-induced demyelination of the central nervous system causes the development of a neurogenic bladder that is comparable with neurogenic detrusor overactivity observed in patients with multiple sclerosis. neurogenic bladder; multiple sclerosis; animal model LOWER URINARY TRACT (LUT) dysfunction is a common complaint in patients with neurological disorders [e.g., multiple sclerosis (MS), Parkinson's disease, and Alzheimer's disease], characterized by significant structural and functional changes in the central nervous system (CNS). The development of therapies for these patients has proven a major challenge because of substantial LUT compromise at the time of clinical presentation. Therefore, understanding the pathophysiological mechanisms of the structural and functional interplay between the urological and nervous systems during the progression of neurodegenerative disorders is vital to facilitate the development of preventative and therapeutic approaches targeting the LUT and ensure their implementation earlier in the course of disease progression.MS is a chronic autoimmune disorder of the CNS, which is predominantly diagnosed in young adults and has long-term implications for their personal and professional l...